Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Income from Continuing Operations came in at -$2.1 million in Q2 2026, down 145.21% year-over-year from $4.6 million in Q2 2025, and up 85.81% quarter-over-quarter from -$14.5 million in Q1 2026.
Powered by 
Analysis
Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Income from Continuing Operations across 9 years of filings, most recently posting -$2.1 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 145.21% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at -$19.4 million (down 105.84% YoY), while the FY2025 annual figure was -$24.2 million, down 232.41% from the prior year.
- Income from Continuing Operations came in at -$2.1 million for Q2 2026 at Castle Biosciences, up from -$14.5 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of $9.6 million in Q4 2024 to a low of -$29.2 million in Q1 2023.
- Average Income from Continuing Operations over 5 years is -$8.2 million, with a median of -$2.6 million recorded in 2023.
- Year-over-year, Income from Continuing Operations sank 1039.38% in 2023 and jumped 471.71% in 2024.
- Over 5 years, Income from Continuing Operations stood at -$20.6 million in 2022, then surged by 87.49% to -$2.6 million in 2023, then jumped by 471.71% to $9.6 million in 2024, then tumbled by 124.32% to -$2.3 million in 2025, then climbed by 11.66% to -$2.1 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$2.1 million in Q2 2026, -$14.5 million in Q1 2026, and -$2.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -66.93 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 324.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 8.51 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -637,000.00 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -16.21 Mn |
| 10 | Castle Biosciences | 1.08 Bn | 811.36 Mn | 79.85 Mn | -2.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.06 Mn |
| Mar 31, 2026 | -14.52 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | -25.85 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | -2.53 Mn |
| Dec 31, 2023 | -2.58 Mn |
| Sep 30, 2023 | -6.91 Mn |
| Jun 30, 2023 | -18.78 Mn |
| Mar 31, 2023 | -29.20 Mn |
| Dec 31, 2022 | -20.62 Mn |
| Sep 30, 2022 | -20.25 Mn |
| Jun 30, 2022 | -1.65 Mn |
| Mar 31, 2022 | -24.62 Mn |
| Dec 31, 2021 | -6.43 Mn |
| Sep 30, 2021 | -11.79 Mn |
API Access
Castle Biosciences Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CSTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CSTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CSTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();